LY2886721

Min.Order / FOB Price:Get Latest Price

0	Negotiable

Min.Order :0
Purity: 95%

Keywords

N-(3-((4aS,7aS)-2-amino-4a,5,7,7a-tetrahydro-4H-furo[3,4-d][1,3]thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide LY2886721

Quick Details

Appearance:Solid powder
Application:For research use only.
PackAge:
ProductionCapacity:
Storage:Store in a cool and dry place and at 0 - 4°C for short term (days to weeks) or -44°C for long term (months to years).
Transportation:

Superiority:

We provide customized and high-quality LY2886721 product for your project.

Details:

LY2886721, under the IUPAC name N-(3-(2-amino-4a,5,7,7a-tetrahydro-4H-furo(3,4-d)(1,3)thiazin-7a-yl)-4-fluorophenyl)-5-fluoropicolinamide, is the first oral small molecule inhibitting Beta secretase (BACE) to reach Phase 2 clinical research. It was developed by Eli Lilly & Co. with the potention to treat Alzheimer's Disease.

View All